Saloua Sadok

Prof. Saloua Sadok

orcid

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 January 2020 in Biological Procedures Online
Verified
Journal Article
Open access
PDF file
NTNawras Talmoudi
Nawras Talmoudi
NGNoureddine Ghariani
Noureddine Ghariani
SSSaloua Sadok
Saloua Sadok
Background: Glycosaminoglycans (GAGs), including hyaluronic acid (HA), dermatan sulfate (DS) and chondroitin sulfate (CS) are essential components of the bone and cartilage tissues. CS isolated from the cartilage tissue of various animals has found application in pharmaceuticals, cosmetics and food industries. In the first part of the present work, three methods were used and compared to extract and purify glycosaminoglycans (GAGs) from the cartilage powder of a local cartilaginous marine species «Scyliorhinus canicula». One of these GAGs, chondroitin sulfate (CS), will be exploited for the development of an anti-osteoarthritis generic at the request of a collaborative pharmaceutical industry. Thus this active ingredient must meet the requirements and tests described by the European Pharmacopoeia (Ph. Eur.). These tests are treated in the second part of this work.Results: Among the three methods that have been applied in the present work, in order to optimize the best process for GAGs preparation, enzymatic hydrolysis with papain followed by deproteinisation using trichloroacetic acid (TCA) was found the best one. The separation of the extracted GAGs using agarose gel electrophoresis, and the identification of bands by Fourier Transform Infrared (FT-IR) Spectroscopy, revealed that the cartilage GAGs of« Scyliorhinus canicula»are exclusively chondroitin sulfate (CS) and dermatane sulfate (DS), with proportions of 12.889 and 87.111% respectively, and that CS is of type C. The extraction technique with papain provides a product with GAGs content of around 90%. The TCA deproteinisation yielded the lowest level of protein (2.8%) in the extracted GAGs, less than 3%, which is the standard required by the European Pharmacopoeia (Ph. Eur.).Cetylpyridinium chloride (CPC) assay suggests that the titration technique, although is introduced by the Ph. Eur. for the determination of CS content, is not an accurate method, and that the values obtained by the optimized and validated HPLC method, described in this work, are more exact.Conclusion: The extracted and purified active ingredient is perfectly conform to the tests described by the Ph. Eur. The results suggest that the co-product ofScyliorhinus caniculawould be a perfect source of molecules of pharmacological interest, obtained by a simple and non-agressive process.

15 June 2018 in Marine Drugs
Verified
Journal Article
Open access
PDF file
ESEmna Ben Slimane
Emna Ben Slimane
SSSaloua Sadok
Saloua Sadok
The acid solubilised collagen (ASC) and pepsin solubilised collagen (PSC) were extracted from the by-products (skin) of a cartilaginous fish (Mustelus mustelus). The ASC and PSC yields were 23.07% and 35.27% dry weight, respectively and were identified as collagen Type I with the presence of α, β and γ chains. As revealed by the Fourier Transform Infrared (FTIR) spectra analysis, pepsin did not alter the PSC triple helix structure. Based on the various type of collagen yield, only PSC was used in combination with chitosan to produce a composite film. Such film had lower tensile strength but higher elongation at break when compared to chitosan film; and lower water solubility and lightness when compared to collagen film. Equally, FTIR spectra analysis of film composite showed the occurrence of collagen-chitosan interaction resulting in a modification of the secondary structure of collagen. Collagen-chitosan-based biofilm showed a potential UV barrier properties and antioxidant activity, which might be used as green bioactive films to preserve nutraceutical products.

13 April 2021 in Marine Drugs
Verified
Journal Article
Open access
PDF file
CMConcetta Maria Messina
Concetta Maria Messina
SMSimona Manuguerra
Simona Manuguerra
RARosaria Arena
Rosaria Arena
GRGiuseppe Renda
Giuseppe Renda
GFGiovanna Ficano
Giovanna Ficano
ASAndrea Santulli
Andrea Santulli
Non-edible parts of crustaceans could be a rich source of valuable bioactive compounds such as the carotenoid astaxanthin and peptides, which have well-recognized beneficial effects. These compounds are widely used in nutraceuticals and pharmaceuticals, and their market is rapidly growing, suggesting the need to find alternative sources. The aim of this work was to set up a pilot-scale protocol for the reutilization of by-products of processed shrimp, in order to address the utilization of this valuable biomass for nutraceutical and pharmaceuticals application, through the extraction of astaxanthin-enriched oil and antioxidant-rich protein hydrolysates. Astaxanthin (AST) was obtained using “green extraction methods,” such as using fish oil and different fatty acid ethyl esters as solvents and through supercritical fluid extraction (SFE), whereas bioactive peptides were obtained by protease hydrolysis. Both astaxanthin and bioactive peptides exhibited bioactive properties in vitro in cellular model systems, such as antioxidant and angiotensin I converting enzyme (ACE) inhibitory activities (IA). The results show higher astaxanthin yields in ethyl esters fatty acids (TFA) extraction and significant enrichment by short-path distillation (SPD) up to 114.80 ± 1.23 µg/mL. Peptide fractions of <3 kDa and 3–5 kDa exhibited greater antioxidant activity while the fraction 5–10 kDa exhibited a better ACE-IA. Lower-molecular-weight bioactive peptides and astaxanthin extracted using supercritical fluids showed protective effects against oxidative damage in 142BR and in 3T3 cell lines. These results suggest that “green” extraction methods allow us to obtain high-quality bioactive compounds from large volumes of shrimp waste for nutraceutical and pharmaceutical applications.


15 April 2010 in Food Chemistry
Verified
Journal Article
Closed access
MAMourad Attouchi
Mourad Attouchi
SSSaloua Sadok
Saloua Sadok

1 August 2008 in Food Science and Technology International
Verified
Journal Article
Closed access
RMR. Mbarki
R. Mbarki
SSSaloua Sadok
Saloua Sadok
IBI. Barkallah
I. Barkallah
This study evaluates the influence of various doses of gamma irradiation on some quality aspects of iced bonito (Sarda sarda). Fresh bonito sections were aerobically packed and gamma irradiated with doses of 0, 1.5, 3, 4.5, 6, and 7.5 kGy, samples were then chilled during 21 days. Microbiological analyses showed the presence of mesophilic and psychrophilic germs just before irradiation treatment. These germs were eliminated at doses ≥1.5 kGy. The analyses of total volatile basic nitrogen (TVB-N), trimethylamine (TMA) as well as the texture analysis showed that irradiated samples preserved a good quality during 21 days of chilled storage, whereas the control showed putrefaction. Histamine content was reduced after irradiation treatment, such decrease strongly correlated with the applied dose level. Fatty acid composition survey demonstrated that gamma irradiation associated with aerobic packaging influenced significantly the lipid profile. Irradiation at doses of 6 and 7.5 kGy reduced significantly poly-unsaturated fatty acid fraction. Results demonstrated that irradiation amplified the rate of lipid oxidation as shown by an increased peroxide value especially at higher doses. Gamma irradiation at low doses was effective in extending the bonito's shelf-life through the improvement of its microbiological, biochemical and textural qualities up to 21 days of chilled storage.